On May 27, some of the world’s largest cannabis manufacturers and globally recognized advocates for medical use of cannabis will come to Stockholm and SMCC […]
Auresacculin will be ready for the Swedish market within 18 months. Pharma company Aureum Life expects the research and development work to be finished in 6–8 months.
Aureum Life is launching its website today. Among other things, it presents the company’s ambitious plans for medical cannabis on the Swedish market, along with several upcoming facilities.